Inventor · disambiguated record
Nathaniel W. Silver
Also filed as: SILVER NATHANIEL · SILVER NATHANIEL W
13 granted patents·27 pending applications·181 citations·filing 2013–2025
92Inventor score
Top patents by PatentIndex Score
40 records- 0195US9700071B2Nutritive fragments, proteins and methodsPRONUTRIA INC·Filed 2013·Granted Jul 11, 2017·40 cites·12 claims
- 0294US8822412B2Charged nutritive proteins and methodsPRONUTRIA INC·Filed 2014·Granted Sep 2, 2014·22 cites·19 claims
- 0394US8809259B2Charged nutritive proteins and methodsPRONUTRIA INC·Filed 2013·Granted Aug 19, 2014·34 cites·17 claims
- 0493US9611298B2Charged nutritive proteins and methodsPRONUTRIA INC·Filed 2014·Granted Apr 4, 2017·16 cites·42 claims
- 0591US10463711B2Nutritive polypeptides and formulations thereof, and methods of production and use thereofAXCELLA HEALTH INC·Filed 2016·Granted Nov 5, 2019·13 cites·18 claims
- 0691US9878004B2Compositions and formulations for treatment of gastrointestinal tract malabsorption diseases and inflammatory conditions and methods of production and use thereofPRONUTRIA INC·Filed 2014·Granted Jan 30, 2018·24 cites·14 claims
- 0791US9605040B2Nutritive proteins and methodsPRONUTRIA INC·Filed 2013·Granted Mar 28, 2017·17 cites·16 claims
- 0889US9598474B2Nutritive fragments, proteins and methodsPRONUTRIA INC·Filed 2013·Granted Mar 21, 2017·14 cites·20 claims
- 0987US2020109175A1Charged Nutritive Proteins and MethodsAXCELLA HEALTH INC·Filed 2019·Application pending·0 cites
- 1087US2024150406A1Charged Nutritive Proteins and MethodsAXCELLA HEALTH INC·Filed 2023·Application pending·0 cites
- 1177US10450350B2Charged nutritive proteins and methodsAXCELLA HEALTH INC·Filed 2017·Granted Oct 22, 2019·1 cites·20 claims
- 1272US2020188481A1Nutritive Polypeptides and Formulations Thereof, and Methods of Production and Use ThereofAXCELLA HEALTH INC·Filed 2019·Application pending·0 cites
- 1368US11357824B2Nutritive polypeptides and formulations thereof, and methods of production and use thereofAXCELLA HEALTH INC·Filed 2020·Granted Jun 14, 2022·0 cites·12 claims
- 1466US2022347262A1Compositions and Formulations and Methods of Production and Use ThereofAXCELLA HEALTH INC·Filed 2021·Application pending·0 cites
- 1562US2025282848A1Non-viral dna vectors and uses thereof for expressing fviii therapeuticsGENERATION BIO CO·Filed 2025·Application pending·0 cites
- 1661US2025352666A1Lipid nanoparticle compositions and uses thereofGENERATION BIO CO·Filed 2023·Application pending·0 cites
- 1759US2015126441A1Nutritive Fragments and Proteins with Low or No Phenylalanine and MethodsPRONUTRIA INC·Filed 2013·Application pending·0 cites
- 1858US12338275B2Non-viral DNA vectors and uses thereof for expressing FVIII therapeuticsGENERATION BIO CO·Filed 2020·Granted Jun 24, 2025·0 cites·17 claims
- 1957US2020405807A1Compositions and Formulations and Methods of Production and Use ThereofAXCELLA HEALTH INC·Filed 2020·Application pending·0 cites
- 2057US2018125926A1Compositions and Formulations and Methods of Production and Use ThereofAXCELLA HEALTH INC·Filed 2017·Application pending·0 cites
- 2157US2024277833A1Non-viral dna vectors for vaccine deliveryGENERATION BIO CO·Filed 2022·Application pending·0 cites
- 2255US2024181085A1Non-viral dna vectors and uses thereof for expressing pfic therapeuticsGENERATION BIO CO·Filed 2022·Application pending·0 cites
- 2355US2024299580A1Apoe and apob modified lipid nanoparticle compositions and uses thereofGENERATION BIO CO·Filed 2022·Application pending·0 cites
- 2454US12415002B2Non-viral DNA vectors and uses thereof for expressing phenylalanine hydroxylase (PAH) therapeuticsGENERATION BIO CO·Filed 2020·Granted Sep 16, 2025·0 cites·21 claims
- 2554US2016228506A1Compositions and Formulations for Prevention and Reduction of Tumorigenesis, Cancer Cell Proliferation and Invasion, and Methods of Production and Use Thereof in Cancer TreatmentPRONUTRIA INC·Filed 2014·Application pending·0 cites
- 2654US2024226324A1Non-viral dna vectors expressing therapeutic antibodies and uses thereofGENERATION BIO CO·Filed 2022·Application pending·0 cites
- 2753US2015232520A1Charged Nutritive Fragments, Proteins and MethodsPRONUTRIA INC·Filed 2013·Application pending·0 cites
- 2852US2024216535A1Non-viral dna vectors expressing anti-coronavirus antibodies and uses thereofGENERATION BIO CO·Filed 2022·Application pending·0 cites
- 2952US2024382432A1Single chain variable fragment (scfv) modified lipid nanoparticle compositions and uses thereofGENERATION BIO CO·Filed 2022·Application pending·0 cites
- 3052US2023134550A1Non-viral dna vectors and uses thereof for expressing gaucher therapeuticsGENERATION BIO CO·Filed 2021·Application pending·0 cites
- 3151US2017327548A1Charged Nutritive Fragments, Proteins and MethodsAXCELLA HEALTH INC·Filed 2017·Application pending·0 cites
- 3250US2023383311A1Non-viral dna vectors and uses thereof for expressing fviii therapeuticsGENERATION BIO CO·Filed 2021·Application pending·0 cites
- 3349US2024026374A1Closed-ended dna vectors and uses thereof for expressing phenylalanine hydroxylase (pah)GENERATION BIO CO·Filed 2021·Application pending·0 cites
- 3448US9944681B2Nutritive fragments, proteins and methodsAXCELLA HEALTH INC·Filed 2017·Granted Apr 17, 2018·0 cites·19 claims
- 3548US2023138409A1Non-viral dna vectors and uses thereof for expressing factor ix therapeuticsGENERATION BIO CO·Filed 2021·Application pending·0 cites
- 3647US2025281647A1Stealth lipid nanoparticle compositions for cell targetingGENERATION BIO CO·Filed 2025·Application pending·0 cites
- 3746US2017298102A1Nutritive Proteins and MethodsAXCELLA HEALTH INC·Filed 2017·Application pending·0 cites
- 3842US2022042035A1Non-viral dna vectors and uses thereof for antibody and fusion protein productionGENERATION BIO CO·Filed 2019·Application pending·0 cites
- 3942US2015307562A1Engineered secreted proteins and methodsPRONUTRIA BIOSCIENCES INC·Filed 2013·Application pending·0 cites
- 4040US2015093495A1Nucleic Acids, Cells, and Methods for Producing Secreted ProteinsPRONUTRIA INC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nathaniel W. Silver files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →